Antengene
RESEARCH FIELD

R&D and Innovation

Scientific and replicable R&D process
In-house R&D Case study - 3D011
  • 01
    Analyze demand

    · Unmet medical needs exist for prostate cancer in China

  • 02
    Identify a product or target

    · Inhibit directly: RAF/MEK

    · Inhibit indirectly: block tumor angiogenesis

  • 03
    R&D

    · Proprietary platform

    · Unique pro-drug design targeted to specific organs and tumor types

  • 04
    3D011 (IND approved)

    Compared to products of similar category:

    other studies shows, VEGF could increase PD-1

    expression on T-cells and mediate

    “exhaustion” of CD8+ T-cells in tumors.